Press release
Persistent Epithelial Defect Market: Regenerative and Biologic Therapies Drive Growth to 2034
Persistent Epithelial Defect Market
Rising incidence of corneal surface injuries, adoption of regenerative eye therapies, and innovation in biologic eye drops are driving steady expansion of the persistent epithelial defect (PED) market worldwide.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72290
Introduction
The Persistent Epithelial Defect (PED) Market is gaining clinical and commercial importance as ophthalmology embraces regenerative medicine, biologic formulations, and advanced wound-healing technologies.
Valued at USD 210 million in 2024, the market is projected to reach USD 420 million by 2034, expanding at a CAGR of 7.1% over the forecast period.
PED refers to a failure of the corneal epithelium to re-epithelialize after injury or surgery, often caused by neurotrophic keratopathy, dry-eye syndrome, or post-LASIK complications. Recent advancements in growth-factor therapies and stem-cell-based solutions are enhancing healing outcomes and reducing vision loss risk.
Key Players in the Market
The PED market comprises ophthalmic leaders and biotech start-ups focused on corneal regeneration and surface repair.
Notable players include:
• Dompé Farmaceutici S.p.A.
• Regeneron Pharmaceuticals Inc.
• Novartis AG (Alcon Division)
• Johnson & Johnson Vision Care Inc.
• Santen Pharmaceutical Co. Ltd.
• Allergan plc (AbbVie Inc.)
• Sun Pharma Industries Ltd.
• KeraMed Inc.
• MIMETAS B.V.
• Horus Pharma
These companies are investing in nerve-growth factor (NGF) treatments, amniotic membrane transplants, and biocompatible drug-delivery systems to accelerate corneal healing and prevent recurrence.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72290/persistent-epithelial-defect-market
Key Events in the Last Five Years
• 2020-2021: Clinical adoption of Oxervate (cenegermin-bkbj) by Dompé marked a turning point in PED management, introducing the first NGF-based therapy.
• 2022: Expansion of biologic eye drops and amniotic membrane grafts in ophthalmic clinics across Europe and Asia.
• 2023: AI-enabled corneal topography systems enhanced diagnostic accuracy for neurotrophic and traumatic PED cases.
• 2024: Start-ups in Japan and the U.S. launched novel stem-cell sheet technologies and nanogel-based corneal patches.
Market Growth Rate
According to Exactitude Consultancy, the PED market is expected to grow at a CAGR of 7.1% from 2025 to 2034, driven by:
• Increased prevalence of ocular surface diseases and post-surgical epithelial defects.
• Emerging biologic and regenerative treatments offering superior efficacy.
• Wider availability of AI-based diagnostic tools and home-care monitoring devices.
• Supportive reimbursement policies for advanced ophthalmic products in developed regions.
Market Segments and Growth Analysis
The PED market is segmented by therapy type, disease cause, and region.
By Therapy Type:
• Biologic Eye Drops (NGF, EGF, and Serum-Derived Formulations)
• Amniotic Membrane Transplants and Corneal Bandages
• Autologous Serum Eye Drops and Platelet-Rich Plasma (PRP)
• Stem-Cell and Gene Therapies
• Supportive Medications (Antibiotics, Lubricants, Corticosteroids)
By Disease Cause:
• Neurotrophic Keratopathy
• Dry Eye Disease
• Post-Surgical and Traumatic Defects
• Infectious and Autoimmune Etiologies
By Region:
• North America: Leads in adoption of NGF therapies and corneal implants.
• Europe: Strong clinical trials network for regenerative ophthalmology.
• Asia Pacific: Rising demand for affordable serum therapies in India, Japan, and China.
• Latin America & MEA: Gradual uptake of autologous formulations and AI screening tools.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72290
Key Market Drivers
1. Regenerative and Biologic Innovation:
NGF-based treatments and stem-cell transplants are restoring epithelial integrity in refractory patients.
2. AI and Digital Diagnostics:
Machine-learning corneal maps enable personalized therapy selection and healing prediction.
3. Rising Surgical Volume:
Increasing LASIK and cataract procedures contribute to higher post-operative PED risk.
4. Expanding Access to Ophthalmic Care:
Tele-ophthalmology and home delivery of biologic eye drops support long-term adherence.
Recent Developments
• 2023: Dompé Farmaceutici expanded Oxervate availability to Latin America and Asia Pacific.
• 2024: Novartis launched a clinical trial for its EGF-enhanced eye drop platform in Europe.
• 2024: Allergan (AbbVie) introduced a next-generation lubricant with bio-adhesive polymers for chronic corneal defects.
• 2024: Japanese research teams announced pre-clinical success for CRISPR-edited epithelial cell therapies for PED.
Expert Insight
"Persistent epithelial defects are among the most challenging corneal conditions. With the integration of growth factor biologics and AI-assisted monitoring, we are now seeing healing rates that were unimaginable a decade ago,"
- Dr. Laura Mendez, Corneal Specialist, Bascom Palmer Eye Institute.
Conclusion
The Persistent Epithelial Defect Market is transitioning from palliative care to curative and regenerative approaches.
As biologic therapies and stem-cell advancements gain regulatory traction, patients worldwide can expect faster recovery and fewer vision loss complications. Combined with AI-powered diagnostics and tele-ophthalmology, the PED market is poised for strong, sustainable growth through 2034.
This report is also available in the following languages : Japanese (持続性上皮欠損市場), Korean (지속성 상피 결손 시장), Chinese (持续性上皮缺陷市场), French (Marché des défauts épithéliaux persistants), German (Markt für persistierende Epitheldefekte), and Italian (Mercato dei difetti epiteliali persistenti), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72290
Amyloidosis Clinical Market
https://exactitudeconsultancy.com/reports/73634/amyloidosis-clinical-market
Women's Digital Health Fundamental Analysis Market
https://exactitudeconsultancy.com/reports/73703/women-s-digital-health-fundamental-analysis-market
Clinical Trial Software Market
https://exactitudeconsultancy.com/reports/73711/clinical-trial-software-market
Robotic Nurse Assistant Market
https://exactitudeconsultancy.com/reports/73888/robotic-nurse-assistant-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Persistent Epithelial Defect Market: Regenerative and Biologic Therapies Drive Growth to 2034 here
News-ID: 4259065 • Views: …
More Releases from Exactitude Consultancy
Scleritis Market: Biologic Advances and Early Diagnosis Drive Growth to 2034
Subheadline:
Growing autoimmune disease awareness, biologic drug adoption, and precision ophthalmology tools are driving steady growth in the global scleritis treatment market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72281
Introduction
The Scleritis Market is witnessing gradual but significant growth as advances in biologic drugs, early autoimmune diagnostics, and ocular immunology research reshape disease management strategies.
Valued at USD 270 million in 2024, the market is projected to reach USD 490 million by…
Mantle Cell Lymphoma Market: Targeted and Cell Therapies Drive Growth to 2034
Subheadline:
Breakthroughs in BTK inhibitors, CAR-T therapy expansion, and growing clinical trial activity are driving the global mantle cell lymphoma (MCL) market toward a transformative decade.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72262
Introduction
The Mantle Cell Lymphoma (MCL) Market is experiencing rapid innovation as targeted therapy advancements, immuno-oncology research, and cell-based treatment approvals reshape the hematologic cancer landscape.
Valued at USD 3.1 billion in 2024, the global market is projected to…
Choroidal Neovascularization Market: Anti-VEGF and AI Advances Fuel Growth to 20 …
Subheadline:
Expanding use of anti-VEGF biologics, AI-assisted retinal imaging, and a rising elderly population propel the global choroidal neovascularization (CNV) market to new heights.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72251
Introduction
The Choroidal Neovascularization (CNV) Market is witnessing strong momentum, supported by rapid adoption of anti-VEGF therapies, AI-based diagnostic imaging, and growing prevalence of retinal diseases such as age-related macular degeneration (AMD) and pathological myopia.
Valued at USD 8.2 billion in…
Vernal Keratoconjunctivitis Market: Biologics and Digital Tools Drive Growth to …
Subheadline:
Rising global prevalence in warm climates, growing use of biologic eye drops, and digital ophthalmology advancements are fueling the vernal keratoconjunctivitis (VKC) market worldwide.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72220
Introduction
The Vernal Keratoconjunctivitis (VKC) Market is expanding steadily as patient awareness, targeted biologic drugs, and improved diagnostic tools transform allergic eye-disease management.
Valued at USD 430 million in 2024, the market is projected to reach around USD 780 million…
More Releases for PED
Persistent Epithelial Defect Market Projected to Grow at 7.4% CAGR, Reaching USD …
Introduction
Persistent epithelial defects (PEDs) are corneal wounds that fail to heal within the expected timeframe despite conventional treatment. These defects are caused by various underlying conditions such as neurotrophic keratopathy, severe dry eye, trauma, chemical burns, or post-surgical complications. If left untreated, PEDs can progress to corneal ulcers, scarring, and even permanent vision loss, making them a serious ophthalmic concern.
The complexity of PED treatment lies in addressing not only the…
Ped-Lock Valves & Fittings
• Company Overview
Established in 1985, Ped Lock is ISO 9001:2015-certified and manufactures a wide range of instrumentation valves, fittings, and hydraulic components.
• Product Portfolio
Includes needle, ball, check, gate, globe, safety/relief, manifold, condensate pot, quick release valves, air headers, hydraulic hose, and more.
• Certifications & Quality Assurance
Equipped with advanced machining, in-house R&D and labs, and rigorous testing (leakage, hydro, helium, seismic, etc.).
• Global Presence
Products are exported worldwide, including to the USA, UK, Germany, Australia, and…
Persistent Epithelial Defect Market Size is Set for Rapid Growth as Innovative T …
The Persistent Epithelial Defect market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Dompe Farmaceutici, Amber Ophthalmics, Kala Bio, Kiora Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Amber Ophthalmics, Inc., Noveome Biotherapeutics, formerly Stemnion, Amber Ophthalmics, Inc.
[Nevada, United States] - DelveInsight's "Persistent Epithelial Defect Market Insights, Epidemiology, and Market Forecast 2034." report offers a…
Foot Care Medicated Creams Market Upcoming Trends, Segmented by Type, Applicatio …
New Jersey, United States,- Mr Accuracy Reports published new research on Global Foot Care Medicated Creams covering micro level of analysis by competitors and key business segments (2022-2029). The Global Foot Care Medicated Creams explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists both qualitative and quantitative…
Pipeline Embolization Device (PED) Market Emerging Trends, Growth Factors, Regio …
Los Angeles-United State: QY Research has recently published a research report titled, "Global Pipeline Embolization Device (PED) Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application" assessing various factors impacting its trajectory. The global Pipeline Embolization Device (PED) market report offers a high-quality, accurate, and comprehensive research study to equip players with valuable insights for making strategic business choices. The research analysts have provided…
Strongly Increasing Market of Gas Scooter Market Report 2019-2025: Top Key Playe …
UpMarketResearch offers a latest published report on “Global Gas Scooter Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 113 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/49493
Gas Scooter Market research report delivers a close…
